Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease

Journal of Clinical Immunology

Volumn 32, Issue 2, 2012, Pages 207-211

  Álvarez Cardona, Aristóteles ^a   Rodríguez Lozano, Ana Luisa ^a   Blancas Galicia, Lizbeth ^a   Rivas Larrauri, Francisco Eduardo ^a   Yamazaki Nakashimada, Marco A ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Chronic granulomatous disease; Hemophagocytic lymphohistiocytosis; Intravenous immunoglobulin; Macrophage activation syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; D DIMER; DEXAMETHASONE; FERRITIN; GAMMA INTERFERON; IMMUNOGLOBULIN; ITRACONAZOLE; MEROPENEM; TRIACYLGLYCEROL; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ABDOMINAL PAIN; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CULTURE; BLOODY DIARRHEA; BURKHOLDERIA CEPACIA; CASE REPORT; CHILD; CHRONIC GRANULOMATOUS DISEASE; CONTINUOUS INFUSION; CYBB GENE; FEVER; GENE; GENE MUTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOMEGALY; HUMAN; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; INTENSIVE CARE; MACROPHAGE ACTIVATION SYNDROME; MALE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS STUTZERI; SEPTIC SHOCK; SPLENOMEGALY; THROMBOCYTOPENIA; ADOLESCENT; GENETICS; INFANT; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MACROPHAGE ACTIVATION SYNDROME; MALE; TREATMENT OUTCOME;

EID: 84863566529     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9616-5     Document Type: Article

References (25)

1. Wintergerst U, Rosenzweig SD, Abinum M, Malech HL, Holland SM, Rezai N. Phagocytes defects. In: Rezai N, Aghamohammadi A, Notarangelo LD, editors. Primary immunodeficiency diseases. Berlin: Springer; 2008. p. 131-59.
2. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical and clinical features of chronic granulomatousdisease. Medicine. 1998;79:170-200.
3. Rosenzweig SD. Inflammatory manifestations in chronic granulomatousdisease. J ClinImmunol. 2008;46:745-9.
4. Grom AA, Mellins ED. Macrophage activation syndrome:advances towards understanding pathogenesis. Curr Opin Rheum.2010;22:561-6.
5. Wulffraat NM. Defining criteria for macrophage activationsyndrome, a process towards early recognition and treatment. JRheum. 2011;38:593-4.
6. Hisano M, Sugawara K, Tatsuzawa O, Kitagawa M, MurashimaA, Yamaguchi K. Bacteria-associated haemophagocytic syndromeand septic pulmonary embolismo caused by Burkholderia cepaciacomplex in a woman with chronic granulomatous disease. J MedMicrobiol. 2007;56:702-5. (Pubitemid 46717500)
7. Sirinavin S, Techasaensiri C, Pakakasama S, Vorachit M, PornkulR, Wacharastin R. Hemophagocytic syndrome in Burkholderiacepacia splenic microabscesses in a child with chronic granulomatousdisease. Pediatr Infect Disease J. 2004;23(9):882-4. (Pubitemid 40221039)
8. Van Montfrans JM, Rudd E, van de Corput L, Henter JI, NikkelsP, Wulffrat N, Boelens JJ. Fatal lymphohistiocytosis in X-linkedchronic granulomatous disease associated with a perforine genevariant. Pediatr Blood Cancer. 2009;52(4):527-9.
9. Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocyticlymphohistiocytosis in children with chronic granulomatousdisease. Pediatr Blood Cancer. 2011;56:460-2.
10. Martín A, Marques L, Soler-Palacin P, Caragol I, Hernández M, Figueras C, et al. Visceral leishmaniasis associated hemophagocyticsyndrome in patients with chronic granulomatous disease. Pediatr Infect Dis J. 2009;28(8):753-4.
11. Araujo A, Pagnier A, Frange P, Wroblewski I, Stasia MJ, MorandP, et al. Lymphohistiocytic activation syndrome and Burkholderiacepacia complex infection in a child revealing chronic granulomatousdisease and chromosomal integration of HHV-6 genome. Arch Pediatr. 2011;18:416-9.
12. Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayri J. Intravenous immunoglobulins in immunodeficiencies: more thanmere replacement therapy. Clin Exp Immunol. 2011;164:2-5.
13. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, et al. Hyperferritinemia as indicator for intravenousimmunoglobulin treatment in reactive macrophage activationsyndrome. Am J Hematol. 2001;68:4-10. (Pubitemid 32738713)
14. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelinesfor hemophagocytic lymphohistiocytosis. Pediatr BloodCancer. 2007;48:124-31. (Pubitemid 44958267)
15. Loyse A, Storring RA, Metzer M. Pseudomonas stutzeri pneumoniain an HIV seropositive patient. J Infect. 2006;53:75-6. (Pubitemid 43960444)
16. Roig P, Orti A, Navarro V. Meningitis due to Pseudomonas stutzeri in a patient infected with human immunodeficiency virus. Clin Infec Dis. 1996;22:587-8. (Pubitemid 26259206)
17. Schappi MG, Jaquet V, Belli DC, Krauze KH. Hyperinflammationin chronic granulomatous disease and anti-inflammatory role of thephagocyte NADPH oxidase. Semin Immunopathol. 2008;30:255-71.
18. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cellsexpress a phagocyte-type NADPH oxidase that is activated alter Tcell receptor stimulation. Nat Immunol. 2004;5(8):818-27. (Pubitemid 39172975)
19. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristicfindings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6 and TNF-alphaproducingmacrophages. Blood. 2005;105:1648-51. (Pubitemid 40223686)
20. Hill HR. Hyperinflammatory pulmonary disease in chronicgranulomatous disease. Pediatr Infect Dis J. 2011;30:808-10.
21. Kay HD, Smith DL, Sullivan G, Mandell GL, Donowitz GR. Evidence for a nonoxidative mechanism of human natural killercell cytotoxicity by using mononuclear effector cells from healthydonors and from patients with chronic granulomatous disease. JImmunol. 1983;131:1784-8. (Pubitemid 13006893)
22. Yamazaki-Nakashimada MA, Siehm ER, Pietropaolo-CienfuegosD, Hernandez-Bautista V, Espinosa-Rosales F. Corticosteroidtherapy for refractory infections in chronic granulomatous disease:case reports and review of the literature. Ann Allergy AsthmaImmunol. 2006;97:257-61. (Pubitemid 44272596)
23. Freeman AF, Marciano BE, Anderson VL, Uzel G, Costas C, Holland SM. Corticosteroids in the treatment of severe nocardiapneumonia in chronic granulomatous disease. Pediatr Infect Dis J.2011;30:806-8.
24. Baumgrass R, Brandt C, Wegner F, Abdollahnia M, Worm M. Low-dose but not high dose, cyclosporin A promotes regulatoryT-cell induction, expansion, or both. J Allergy Clin Immunol.2010;126:183-4.
25. Steinbach WJ. Calcineurin pathway inhibition: a novel antifungalstrategy. J Invas Fung Infect. 2010;4:1-7.